Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians
DOI: 10.1055/s-0043-1774811
Original Article

Platelet and Erythrocyte Parameters in Type 2 Diabetic Moroccan Patients: A Cross-Sectional Study

Ibtissam Mhirig
1   Department of Biochemistry, Arrazi Hospital, Mohammed VI University Hospital, Marrakech, Morocco
2   Faculty of Medicine and Pharmacy of Marrakech, Cadi Ayyad University, Marrakech, Morocco
4   Department of Hematology, Arrazi Hospital, Mohammed VI University Hospital, Marrakech, Morocco
,
Sara Harrar
1   Department of Biochemistry, Arrazi Hospital, Mohammed VI University Hospital, Marrakech, Morocco
2   Faculty of Medicine and Pharmacy of Marrakech, Cadi Ayyad University, Marrakech, Morocco
,
Leila Habibi
2   Faculty of Medicine and Pharmacy of Marrakech, Cadi Ayyad University, Marrakech, Morocco
3   Department of Rheumatology, Mohammed VI University Hospital, Marrakech, Morocco
,
Sanae Sayagh
2   Faculty of Medicine and Pharmacy of Marrakech, Cadi Ayyad University, Marrakech, Morocco
4   Department of Hematology, Arrazi Hospital, Mohammed VI University Hospital, Marrakech, Morocco
,
Siham Aboulmakarim
1   Department of Biochemistry, Arrazi Hospital, Mohammed VI University Hospital, Marrakech, Morocco
2   Faculty of Medicine and Pharmacy of Marrakech, Cadi Ayyad University, Marrakech, Morocco
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Introduction Complete blood count parameters have gained renewed interest as predictors of endothelial dysfunction in type 2 diabetes mellitus (T2DM). Thus, the aim of this study was to observe the changes in platelet and erythrocyte parameters between diabetics and nondiabetics and to evaluate these changes in relation to glycemic control.

Materials and Methods This cross-sectional study was performed in Mohammed VI University Hospital, Marrakech, Morocco, from January 2020 to July 2021. A total of 307 Moroccan patients were enrolled in this study, which included 222 diabetic patients and 85 nondiabetics. The diabetic patients were divided into two groups A (hemoglobin A1c [HbA1c] ≥ 6.5%) and B (HbA1c < 6.5%) according to their glycated hemoglobin levels (HbA1c). Biological parameters were processed as per the standard technique. Data analysis was performed using SPSS statistical software.

Results A significant difference was mentioned regarding mean corpuscular volume (MCV) (p < 0.001), red blood cell distribution width (RDW) (p < 0.001), and volume/platelet count (p = 0.023) between diabetics and nondiabetics. MCV and RDW were lower in group B than group A (p = 0.004; p = 0.04), while MPV was higher (p = 0.342). RDW significantly and negatively correlated with HbA1c in diabetic population (r = –0.182; p = 0.006). On the other hand, a significant and positive correlation between MPV and HbA1c was mentioned (r = +0.184; p = 0.006).

Conclusion Our study showed that RDW and MPV correlate with HbA1c in T2DM and can be used as a reproducible and inexpensive means to ensure proper control of glycemic status. Further studies are warranted to define specific RDW and MPV values predictive of complication risk in the diabetic population.

Keywords

glycated hemoglobin - mean platelet volume - red cell distribution width - type 2 diabetes mellitus

Note

An earlier presentation was not applicable.


Statement of Institutional Review Board Approval

The members of the research ethics committee reviewed the protocol on May 18, 2023 and according to the Law 28–13 regarding the protection of persons participating in research: The study is approved (attached letter of approval).


Authors' Contributions

- I.M.: Provided substantial contribution to the conception and design of the study, contributed to the acquisition, analysis and interpretation of data for the work, drafted the manuscript, and gave final approval of the version to be published.


- L.H.: Specialist in rheumatology with a Master's degree in SPSS software who helped in the statistical analysis.


- S.H.: Assisted in determining the exclusion criteria and in the careful selection of eligible patients for the case series study.


- S.S.: Assisted in the smooth running of preanalytical and analytical phases of the samples intended for the realization of blood counts.


- AS.A.: Supervised this case series study from conception to interpretation of data and critically revised the work for important intellectual content.




Publication History

Received: 15 June 2023

Accepted: 11 July 2023

Article published online:
18 September 2023

© 2023. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin A. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019; 157: 2000-2006
    CrossrefPubMedGoogle Scholar
  • 2 Melissa JG. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes | diabetes care. Clin Biochem Rev 2009; 32 (07) 1327-1334
    Google Scholar
  • 3 Agu K. Diabetes mellitus: a review of some of the prognostic markers of response to treatment and management. JInsulResist 2019; 3: 222-225
    Google Scholar
  • 4 Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol 2018; 17 (01) 121
    CrossrefPubMedGoogle Scholar
  • 5 Demirtas L, Degirmenci H, Akbas EM. et al. Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med 2015; 8 (07) 11420-11427
    PubMedGoogle Scholar
  • 6 Bilgin S, Aktas G, Zahid Kocak M. et al. Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men. Aging Male 2020; 23 (05) 923-927
    CrossrefPubMedGoogle Scholar
  • 7 Zuberi BF, Akhtar N, Afsar S. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. Singapore Med J 2008; 49 (02) 114-116
    PubMedGoogle Scholar
  • 8 Nada AM. Red cell distribution width in type 2 diabetic patients. Diabetes Metab Syndr Obes 2015; 8: 525-533
    CrossrefPubMedGoogle Scholar
  • 9 Mbata C, Adegoke A, Chinyere N, Nyeso WA. Some haematological parameters in diabetic patients in Port Harcourt Nigeria. Asian J Multidiscip Stud 2015; 3: 21-25
    Google Scholar
  • 10 Bhutto AR, Abbasi A, Abro AH. Correlation of hemoglobin A1c with red cell width distribution and other parameters of red blood cells in type II diabetes mellitus. Cureus 2019; 11 (08) e5533
    PubMedGoogle Scholar
  • 11 Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med 2009; 169 (06) 588-594
    CrossrefPubMedGoogle Scholar
  • 12 Felker GM, Allen LA, Pocock SJ. et al; CHARM Investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50 (01) 40-47
    CrossrefPubMedGoogle Scholar
  • 13 Shao Q, Korantzopoulos P, Letsas KP. et al. Red blood cell distribution width as a predictor of atrial fibrillation. J Clin Lab Anal 2018; 32 (05) e22378
    CrossrefPubMedGoogle Scholar
  • 14 Borné Y, Smith JG, Melander O, Hedblad B, Engström G. Red cell distribution width and risk for first hospitalization due to heart failure: a population-based cohort study. Eur J Heart Fail 2011; 13 (12) 1355-1361
    CrossrefPubMedGoogle Scholar
  • 15 Tsilingiris D, Makrilakis K, Barmpagianni A. et al. The glycemic status determines the direction of the relationship between red cell distribution width and HbA1c. J Diabetes Complications 2021; 35 (10) 108012
    CrossrefPubMedGoogle Scholar
  • 16 Chinmay S, Manjula SD, Bekur R, Rao K. Association of increased levels of glycated hemoglobin with variations in red blood cell parameters in diabetes mellitus. Int J Adv Res (Indore) 2018; 4: 31-37
    Google Scholar
  • 17 Farooqi R, Afsar N, Akhtare IA. Role and significance of hematological parameters in diabetes mellitus. Ann Pathol Lab Med 2019; 6: 200-202
    Google Scholar
  • 18 Nombwende G, Adhav MP, Kavwanga EY. Mean corpuscular volume (MCV): a suitable marker for the diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients. TEXILA Int J Clin Res 2019; 6: 32-44
    CrossrefGoogle Scholar
  • 19 Adane T, Getaneh Z, Asrie F. Red blood cell parameters and their correlation with renal function tests among diabetes mellitus patients: a comparative cross-sectional study. Diabetes Metab Syndr Obes 2020; 13: 3937-3946
    CrossrefPubMedGoogle Scholar
  • 20 Waggiallah H, Alzohairy M. The effect of oxidative stress on human red cells glutathione peroxidase, glutathione reductase level, and prevalence of anemia among diabetics. N Am J Med Sci 2011; 3 (07) 344-347
    CrossrefPubMedGoogle Scholar
  • 21 Cakir L, Aktas G, Enginyurt O. et al. Mean platelet volume increases in type 2 diabetes mellitus independent of HbA1c level. Acta Med Mediter 2014; 30: 210-211
    Google Scholar
  • 22 Akinsegun A, Akinola Olusola D, Sarah JO. et al. Mean platelet volume and platelet counts in type 2 diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria. Pan Afr Med J 2014; 18: 42
    CrossrefPubMedGoogle Scholar
  • 23 Harsha P, Tripati BK. A study on correlation of mean platelet volume with HbA1c in type 2 diabetes mellitus. J Assoc Physicians India 2023; 71 (01) 1
    PubMedGoogle Scholar
  • 24 Lippi G, Salvagno GL, Nouvenne A, Meschi T, Borghi L, Targher G. The mean platelet volume is significantly associated with higher glycated hemoglobin in a large population of unselected outpatients. Prim Care Diabetes 2015; 9 (03) 226-230
    CrossrefPubMedGoogle Scholar
  • 25 Razak MKA, Akif AM, Nakeeb N, Rasheed JI. The relationship between mean platelet volume and albuminuria in patients with type 2 diabetes mellitus. Diabetes Metab Syndr 2019; 13 (04) 2633-2639
    CrossrefPubMedGoogle Scholar
  • 26 Inoue H, Saito M, Kouchi K, Asahara S-I, Nakamura F, Kido Y. Association between mean platelet volume in the pathogenesis of type 2 diabetes mellitus and diabetic macrovascular complications in Japanese patients. J Diabetes Investig 2020; 11 (04) 938-945
    CrossrefPubMedGoogle Scholar
  • 27 Agrawal J, Singh VB, Meena B, Yadav R, Shareef M, Saini V. Mean platelet volume (MPV) the neglected marker of cardiovascular risk and glycosylated hemoglobin in diabetic patient. Diabetes Metab Syndr 2017; 11 (02) 109-112
    CrossrefPubMedGoogle Scholar